Ligand Pharmaceuticals Inc (LGND)
CapEx to Revenue
0.04%
Quarterly · Period ending:
LGND CapEx to Revenue
Latest reported0.04%period ending
Latest reported0.04%period ending
LGND Quarterly CapEx/Revenue (8.70% → 0.04%)
Latest values, visible window
High-resolution chart · PNG
LGND capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0.0408% | |
| 0.4408% | |
| 0.0151% | |
| 0.013% | |
| 0.4493% | |
| 0.4721% | |
| 1.6631% | |
| 27.4859% | |
| 5.1504% | |
| 0.339% | |
| 1.4839% | |
| 1.4817% | |
| 0.7699% | |
| 5.489% | |
| 7.8795% | |
| 8.931% | |
| 13.1429% | |
| 13.3503% | |
| 3.0287% | |
| 2.7331% | |
| 5.6616% | |
| 6.1723% | |
| 6.3695% | |
| 4.8676% | |
| 1.9097% | |
| 0% | |
| 9.4545% | |
| 0% | |
| 0% | |
| 0% | |
| 18.2698% | |
| 0% | |
| 0% | |
| 1.7807% | |
| 3.8364% | |
| 0.0629% | |
| 0.4001% | |
| 17.3745% | |
| 4.6851% | |
| 10.1115% | |
| 95.6047% | |
| 19.1716% | |
| 8.8005% | |
| 7.2199% | |
| 24.2317% | |
| 22.3052% | |
| 11.1444% | |
| 1.7832% | |
| 0.4242% | |
| 10.1767% | |
| 6.806% | |
| 1.5763% | |
| 38.5386% | |
| 0.3176% | |
| 58.7532% | |
| 5.8353% | |
| 4.2146% | |
| 0.3371% | |
| 0.2938% | |
| 1.9335% | |
| 0% | |
| 0.1283% | |
| 34.8985% | |
| 0.0641% | |
| 23.7067% | |
| 0.9399% | |
| 0.1073% | |
| 2.7465% | |
| 1.3958% | |
| 2.2598% | |
| 0.3309% | |
| 1.3148% | |
| 3.9342% | |
| 4.0213% | |
| 1.2305% | |
| 0.6936% | |
| 17.3759% | |
| 36.5957% | |
| 0.5596% | |
| 2.5009% | |
| 0.999% | |
| 0.3729% | |
| 0.5462% | |
| 80.2719% | |
| 1.1965% | |
| 1.6142% | |
| 2.0599% | |
| 1.6607% | |
| 2.6421% | |
| 2.6002% | |
| 2.6767% | |
| 2.5445% | |
| 0.7107% | |
| 1.0293% | |
| 1.0284% | |
| 2.8061% | |
| 3.5271% | |
| 6.0074% | |
| 1.9565% | |
| 0.9961% |